On the morning of April 10, 2015, Zhejiang Yili Capsule Co., Ltd. successfully listed the new third board, becoming the first listed company in the national capsule industry. Securities abbreviation: Yili Capsule, Securities Code: 832174. Zhejiang Yili Capsule Co., Ltd. is a provincial-level high-tech enterprise integrating scientific research, production and sales. It is the director of China Medical Packaging Association and vice-chairman of Zhejiang Medical Packaging Industry Association. Major well-known pharmaceutical companies, and exports to the United States, Russia, Singapore, Thailand and other countries and regions, enjoy a high reputation in the industry.

        By listing on the new third board, we can enhance the image of the enterprise, enhance the credibility of the enterprise, brand influence, employee loyalty, reduce the enterprise's own credit risk, and help investors to find enterprise value. Yili Capsule will take the opportunity of listing, seize the opportunity, take advantage of the situation, according to the requirements of modern enterprise system, make good use of the capital market, increase the strength of independent innovation, accelerate the enterprise to become bigger and stronger, and strive to become the benchmark and leader of the capsule industry.